Skip to content

MusiCI - Music Therapy in Early Rehabiliation after Cochlear Implantation - impact on speech comprehension

MusiCI - Music Therapy in Early Rehabiliation after Cochlear Implantation - impact on speech comprehension - MusiCI

Status
Recruiting
Phases
Phase 3
Study type
Interventional
Source
DRKS
Registry ID
DRKS00013454
Enrollment
60
Registered
2017-12-05
Start date
2017-12-01
Completion date
Unknown
Last updated
2025-04-07

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Early Rehabilitation following cochlear implantation - impact of music therapy Z96.2

Interventions

Group 1: Music Therapy, main focus on prosody (6 session individual music therapy à 50 minutes, during the time period 3-6 months after the initial activation of the speech processor)
Standard care in early rehabilitation (overall 16 "reha-days" during the first 12 months
contents are: fitting of the speech processor, auditory training, audiotherapy, group counseling, medical care) Group 2: Music Therapy, main focus on auditory rehabilitation (music perception and appr
contents are: fitting of the speech processor, auditory training, audiotherapy, group counseling, medical care) Group 3: waiting list control group without specific music therapy but standard care in
contents are: fitting of the speech processor, auditory training, audiotherapy, group counseling, medical care)

Sponsors

Deutsches Zentrum für Musiktherapieforschung DZM e.V.
Lead Sponsor

Eligibility

Sex/Gender
All
Age
18 Years to No maximum

Inclusion criteria

Inclusion criteria: • Postlinguale deafness • native speaker competence in German language • unilateral cochlear implant (any commonly used device with medical certification, independent from manufacturer) • age = 18 years • Surgery, initial fitting of the speech processor and early rehabiliation at the ENT-clinic of the Heidelberg University Hospital

Exclusion criteria

Exclusion criteria: • prelingual or congenital deafness • bilateral cochlear implant • clinical diagnosis of a serious mental, neurological or psychiatric disease (e.g. psychosis, epilepsy, Parkinson’s disease, dementia, drug or alcohol addiction) • status post traumatic brain injury or cerebral ischemia • psychotropic medication that cannot be discontinued before the cochlear implantation • Inability to speak, read and/or comprehend German language • Inability to give written consent

Design outcomes

Primary

MeasureTime frame
Main objectives are evaluation of hearing performance assessed by both objective tests (pure-tone audiometry, speech in noise tests, PC-based test on prosody ProsA), musical accuracy) and validated questionnaires (Hearing Implant Sound Quality Index, HISQUI) at three measurement times (3, 6, 12 months after initial activation of the speech processor)

Secondary

MeasureTime frame
NCIQ ((Nijmegen Cochlear Implantation Questionnaire): Subjective quality of life MUMU (Munich Music questionnaire): Music listening habits and musical appraisal at three measurement times (3, 6, 12 months after initial activation of the speech processor)

Countries

Germany

Contacts

Public ContactHeike Argstatter

Deutsches Zentrum für Musiktherapieforschung DZM e.V.

dzm@dzm-heidelberg.de+46-6221-833860

Outcome results

None listed

Source: DRKS (via WHO ICTRP) · Data processed: Feb 4, 2026